Application 078477
- Type
- ANDA
- Sponsor
- AMNEAL PHARMS NY
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | TABLET;ORAL | EQ 2.5MG BASE | No | No |
| 002 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | TABLET;ORAL | EQ 5MG BASE | No | No |
| 003 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | TABLET;ORAL | EQ 10MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078477-001 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | ||
| A078477-002 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | ||
| A078477-003 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078477-002 | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET / ORAL | 2008-01-16 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A078477-003 | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET / ORAL | 2008-01-16 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A078477-001 | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET / ORAL | 2008-01-16 | 301d65b070ca… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Amlodipine Besylate | AMLODIPINE BESYLATE | REMEDYREPACK INC. | 204f27e9-5041-4677-b313-866ca69abad9 | 2026-02-13 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 4a2bba2d-9b7a-f43a-e063-6294a90af80e | 2026-02-06 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 41496b0d-f1ca-4e9d-e063-6394a90aec1d | 2026-01-29 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE 5 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 49104797-8202-1376-e063-6294a90adb38 | 2026-01-23 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 3ab4ad3d-7795-058a-e063-6294a90abc86 | 2026-01-23 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | 743ae641-14e1-456b-80e6-c6f7d621e969 | 2026-01-16 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Preferred Pharmaceuticals Inc. | 6e038d92-09f3-4517-947e-146d007114b8 | 2026-01-14 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | AvKARE | feb9438a-9cbc-4855-e053-6394a90af15e | 2026-01-13 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE 10 mg | AMLODIPINE BESYLATE | Aphena Pharma Solutions - Tennessee, LLC | 47e494d2-8971-3f8f-e063-6394a90adb20 | 2026-01-08 | Warnings, Adverse reactions | AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | PD-Rx Pharmaceuticals, Inc. | e01efe66-2f31-4261-92ca-0b41f27104da | 2026-01-07 | Warnings, Adverse reactions | AMLODIPINE BESYLATE AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Northwind Health Company, LLC | f2b8274b-d849-6793-e053-2a95a90aa0e8 | 2026-01-01 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Northwind Health Company, LLC | f32bb322-68d7-a4ca-e053-2995a90aa7b0 | 2026-01-01 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Northwind Health Company, LLC | 0c5784b9-5542-144f-e063-6394a90a7ebc | 2026-01-01 | Warnings, Adverse reactions | AMLODIPINE BESYLATE AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Northwind Health Company, LLC | 03fe9ad2-3a1a-78db-e063-6294a90a2ed3 | 2026-01-01 | Warnings, Adverse reactions | AMLODIPINE BESYLATE AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Northwind Health Company, LLC | 0de6a6d0-a114-e114-e063-6394a90a34dd | 2025-12-26 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Epic Pharma, LLC | 090f3e51-8129-4b5d-97f9-ab410e14df2d | 2025-12-17 | Warnings, Adverse reactions | AMLODIPINE BESYLATE AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Ascend Laboratories, LLC | 2b0bcb95-dc85-46f7-8b69-ca55cd58b30e | 2025-12-10 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | QPharma Inc | 3f74ed2b-4712-4026-ac2c-9239a211dde3 | 2025-12-05 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
| AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | Cipla USA Inc. | 5409b296-3bed-47cd-abba-9fe6f6833af6 | 2025-12-03 | Warnings, Adverse reactions | AMLODIPINE BESYLATE AMLODIPINE BESYLATE |
| Amlodipine Besylate | AMLODIPINE BESYLATE | Boswell Pharmacy Services LLC d/b/a BPS Wholesale | 41af64c4-b788-d827-e063-6394a90a9157 | 2025-10-21 | Warnings, Adverse reactions | Amlodipine Besylate AMLODIPINE BESYLATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 58517-120 | AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | New Horizon Rx Group, LLC | ANDA | Current |
| 65162-006 | Amlodipine Besylate | Amlodipine Besylate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-006 | Amlodipine Besylate | Amlodipine Besylate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-006 | Amlodipine Besylate | Amlodipine Besylate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-006 | Amlodipine Besylate | Amlodipine Besylate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-007 | Amlodipine Besylate | Amlodipine Besylate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-007 | Amlodipine Besylate | Amlodipine Besylate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-007 | Amlodipine Besylate | Amlodipine Besylate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-007 | Amlodipine Besylate | Amlodipine Besylate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-008 | Amlodipine Besylate | Amlodipine Besylate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-008 | Amlodipine Besylate | Amlodipine Besylate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-008 | Amlodipine Besylate | Amlodipine Besylate | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-008 | Amlodipine Besylate | Amlodipine Besylate | Amneal Pharmaceuticals LLC | ANDA | Current |